论文部分内容阅读
从日前召开的“上海医药系统党政负责干部会议”上传出信息:上海医药行业以自我加压、负重奋进的饱满精神状态,刻意追求更高的发展目标,今年上半年继续保持高速发展势头。全局完成工业总产值同比增长28.3％,实现利润同比增长6.5％,完成销售产值50.38亿元,达到了双过半的要求,为实现市府领导今年年初提出的超百亿目标打下了扎实基础。
From the “Shanghai Pharmaceutical System Party and Government Responsible Cadre Conference” held recently, the information was uploaded: The Shanghai pharmaceutical industry, with its full spirit of self-pressurization and weight-bearing, has deliberately pursued higher development goals and maintained rapid development momentum in the first half of this year. The overall industrial output value of the industry has increased by 28.3% year-on-year, profits have increased by 6.5% year-on-year, and the sales value has reached 5.038 billion yuan, which has met the requirement of double-half and has laid a solid foundation for achieving the ultra-billion target proposed by the municipal leaders earlier this year.